SI-BONE, Inc. is a pioneering medical device company dedicated to developing and commercializing minimally invasive surgical (MIS) solutions for the sacropelvic anatomy. Their flagship product, the iFuse Implant System®, provides a less invasive alternative for sacroiliac (SI) joint fusion to treat SI joint dysfunction, a common cause of lower back pain. SI-BONE is committed to improving patient outcomes through innovative technologies, extensive clinical research, and robust physician education. From an end-user perspective, particularly for patients suffering from chronic SI joint pain, SI-BONE offers a clinically proven treatment option that can lead to significant pain relief, improved function, and enhanced quality of life when conservative therapies have failed. For surgeons, SI-BONE provides a reliable and well-supported system for addressing complex sacropelvic conditions.
The headquarters serves as the central hub for corporate leadership, research and development (R&D), strategic planning, global marketing, finance, and administrative functions. Key decisions regarding product innovation, clinical trials, and market expansion are driven from this location.
Being situated in Silicon Valley, the headquarters benefits from proximity to a vast talent pool in engineering, R&D, and medical technology, fostering innovation. The office space is likely designed to support collaborative work and cutting-edge research, typical of a leading medical device firm.
From an employee or partner perspective, the work culture at SI-BONE's HQ is characterized by a dynamic, innovative environment focused on medical advancement and patient well-being. There is a strong emphasis on collaboration, scientific rigor, quality, and a shared mission to improve lives, driven by the critical nature of their medical products.
For patients and medical professionals, the HQ's location in a premier tech and med-tech hub signifies SI-BONE's commitment to leveraging advanced technology and research in developing its sacropelvic solutions. It underscores the company's dedication to innovation in addressing complex spinal and pelvic conditions.
SI-BONE has established a significant global presence with direct sales operations in the United States and several European countries, complemented by a network of international distributors in other key markets. The company actively supports global functions including commercial operations, distribution partnerships, extensive clinical research programs, and comprehensive physician training initiatives across North America, Europe, and select countries in Asia-Pacific and the Middle East. Their innovative sacropelvic solutions are utilized to treat patients in numerous countries, reflecting a growing worldwide adoption of their minimally invasive technologies for SI joint dysfunction and pelvic conditions.
471 El Camino Real, Suite 101
Santa Clara
CA
USA
Address: Medical Device Factory (MDF), Galway Business Park, Parkmore, Galway, Ireland
To effectively support and expand SI-BONE's commercial presence and operations across the EMEA region and other international markets. This includes ensuring localized clinical support, managing regional distribution networks, and navigating diverse regulatory and reimbursement landscapes.
Address: SI-Bone GmbH, Harrlachweg 4, 68163 Mannheim, Germany
To provide dedicated, in-market support for surgeons, hospitals, and distributors within Germany and surrounding German-speaking countries. This allows SI-BONE to cater to specific local healthcare system needs, manage regional sales effectively, and ensure compliance with national regulations.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, SI-BONE' leadership includes:
SI-BONE has been backed by several prominent investors over the years, including:
Over the past 12-18 months, SI-BONE has strategically strengthened its executive leadership team with key appointments, including a new Chief Financial Officer, a new Chief Commercial Officer, and a new Chief People and Culture Officer. These changes are aimed at supporting the company's ongoing growth, commercial expansion, and innovation in the sacropelvic solutions market.
Discover the tools SI-BONE uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
SI-BONE typically uses a standard corporate email format that combines an employee's first initial with their full last name. This common structure facilitates professional communication both internally and with external partners, clinicians, and stakeholders.
[first_initial][last]@si-bone.com
Format
lfrancis@si-bone.com
Example
90%
Success rate
GlobeNewswire • May 7, 2024
SI-BONE announced Q1 2024 revenue of $38.6 million, a 27% increase year-over-year. Worldwide active surgeons grew 21% to approximately 950. The company updated its full year 2024 revenue guidance to $164 million to $167 million....more
GlobeNewswire • February 27, 2024
SI-BONE reported fourth quarter 2023 revenue of $42.1 million, an increase of 28% year-over-year, and full-year 2023 revenue of $137.4 million, up 30%. The company provided initial full-year 2024 revenue guidance of $161 million to $164 million....more
GlobeNewswire • January 8, 2024
SI-BONE announced preliminary unaudited revenue for the fourth quarter of 2023 to be approximately $42.0 million to $42.3 million, representing growth of 27% to 28% compared to the prior year period. Preliminary full-year 2023 revenue is expected to be $137.3 million to $137.6 million, a growth of 30%....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including SI-BONE, are just a search away.